SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth. The new operating model introduces dedicated leadership ...
RMD is seeing rising device demand, expanding international sales and strong liquidity, but macroeconomic pressures could ...
Lessons learned from implementing in AI at regulated medical device manufacturer, ResMed. This includes top 5 challenges and ...
Justin Leong appointed Chief Product Officer, effective immediately. Katrin Pucknat appointed Chief Marketing Officer, effective immediately. Mike Fliss appointed Chief Revenue Officer, effective ...